Introduction: Intradialytic hypotension remains the most common complication for outpatient hemodialysis, and relative blood volume monitoring was designed to reduce hypotension. Reports of the usefulness of this technology, however, have been variable. Methods: We audited the usefulness of relative blood volume monitoring recorded throughout the mid-week dialysis in 72 stable adult outpatients who had multifrequency bioimpedance measurements. Results: The blood volume measurement (BVM) at the end of the session was 91.6 ± 0.6% and was not different from the nadir BVM recorded (90.7 ± 0.5). The BVM was strongly correlated with change in hematocrit (r = –0.56, p < 0.001) and albumin (r = –0.69, p < 0.001), but had no relationship with pre-, intra- or postdialysis blood pressure recordings. The BVM was not associated with ultrafiltration volume, but did correlate with a postdialysis change in extracellular fluid volume (r = –0.39, p = 0.006). Conclusion: In this audit, although the BVM at the end of the dialysis session was correlated with changes in hematocrit, serum albumin and extracellular fluid volume, the change in the relative BVM did not mirror changes in intradialytic blood pressure.

Keywords:
Extracellular fluid, Relative blood volume monitoring, Hemodialysis, Hematocrit, Bioimpedance
1.
Davenport A: Intradialytic complications during haemodialysis. Hemodial Int 2006;10:162–167.
2.
Davenport A, Cox C, Thuraisingham R: Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension. Kidney Int 2008;73:759–764.
3.
Santoro A, Mancini E, Paolini F, Cavicchioli G, Bosetto A, Zucchelli P: Blood volume regulation during hemodialysis. Am J Kidney Dis 1998;32:739–748.
4.
Ronco C, Brendolan A, Milan M, Rodeghiero MP, Zanella M, La Greca G: Impact of biofeedback-induced cardiovascular stability on hemodialysis tolerance and efficiency. Kidney Int 2000;58:800–808.
5.
Andrulli S, Colzani S, Mascia F, Lucchi L, Stipo L, Bigi MC, Crepaldi M, Redaelli B, Albertazzi A, Locatelli F: The role of blood volume reduction in the genesis of intradialysis hypotension. Am J Kidney Dis 2002;40:1244–1254.
6.
Reddan DN, Szczech LA, Hasselbad V: Intradialytic blood volume monitoring in ambulatory haemodialysis patients: a randomised trial. J Am Soc Nephrol 2005;16:2162–2169.
7.
Mancini E, Mambelli E, Irpinia M, Gabrielli D, Cascone C, Conte F, Meneghel G, Cavatorta F, Antonelli A, Villa G, Dal Canton A, Cagnoli L, Aucella F, Fiorini F, Gaggiotti E, Triolo G, Nuzzo V, Santoro A: Prevention of dialysis hypotension episodes using fuzzy logic control system. Nephrol Dial Transplant 2007;22:1420–1427.
8.
Schmidt R, Roeher O, Hickstein H, Korth S: Prevention of hemodialysis induced hypotension by biofeedback control of ultrafiltration and infusion. Nephrol Dial Transplant 2001;16:595–603.
9.
Dasselaar JJ, Lub-de Hooge MN, Pruim J, Nijnuis H, Wiersum A, de Jong PE, Huisman RM, Franssen CFM: Relative blood volume changes underestimate total blood volume changes during hemodialysis. Clin J Am Soc Nephrol 2007;2:669–674.
10.
Davenport A: Membrane designs and composition for hemodialysis, hemofiltration and hemodialfiltration: past, present and future. Minerva Urol Nefrol 2010;62:29–40.
11.
Davenport A, Willicombe M: Comparison of fluid status in patients treated by different modalities of peritoneal dialysis using multi-frequency bioimpedance. Int J Artif Organs 2009;32:779–786.
12.
Bedogni G, Malavolti M, Severi S, Poli M, Mussi C, Fantuzzi AL, Battistini N: Accuracy of an eight-point tactile-electrode impedance method in the assessment of total body water. Eur J Clin Nutr 2002;56:1143–1148.
13.
Booth J, Pinney J, Davenport A: The effect of vascular access modality on changes in fluid content in the arms as determined by multifrequency bioimpedane. Nephrol Dial Transplant 2010, E-pub ahead of print.
14.
Dasselaar JJ, Huisman RM, De Jong PE, Franssen CFM: Relative blood volume measurements during haemodialysis: comparisons between three non-invasive devices. Haemodial Int 2007;11:448–455.
15.
Bogaard HJ, de Vries JP, de Vries PM: Assessment of refill and hypovolaemia by continuous surveillance of blood volume and extracellular fluid volume. Nephrol Dial Transplant 1994;9:1283–1287.
16.
Zhu F, Leonard EF, Levin NW: Extracellular fluid redistribution during haemodialysis: bioimpedance measurement and model. Physiol Measure 2008;29:S491–S501.
17.
Booth J, Pinney J, Davenport A: N-terminal proBNP – marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis Patients? Clin J Am Soc Nephrol 2010;5:1036–1040.
18.
Agarwal R, Kelley K, Light RP: Diagnostic utility of blood volume monitoring in haemodialysis patients. Am J Kid Dis 2008;51:242–254.
19.
Davenport A: Audit of the effect of dialysate sodium concentration on inter-dialytic weight gains and blood pressure control in chronic haemodialysis patients. Nephron Clin Pract 2006;104:c120–c125.
20.
Davenport A, Cox C, Thuraisingham R, PanThames Renal Audit Group. The importance of dialysate sodium concentration in determining interdialytic weight gains in chronic hemodialysis patients: the PanThames Renal Audit. Int J Artif Organs 2008;31:411–417.
21.
Dasselaar JJ, Slart RH, Knip M, Pruim J, Tio RA, McIntyre CW, de Jong PE, Franssen CF: Hemodialysis is associated with a pronounced fall in myocardial perfusion. Nephrol Dial Transplant 2009;24:604–610.
22.
Davenport A, Cox C, Thuraisingham R: Blood pressure control and symptomatic intradialytic hypotension in diabetic hemodialysis patients: a cross sectional survey. Nephron Clin Pract 2008;109:c65–c71.
23.
Bemelmans RH, Boerma EC, Barendregt J, Ince C, Rommes JH, Sprank PE: Changes in the volume status of haemodialysis patients are reflected in sublingual microvascular perfusion. Nephrol Dial Transplant 2009;24:3487–3492.
24.
Davenport A: Can advances in haemodialysis machine technology prevent intradialytic hypotension ? Semin Dial 2009;22:231–236.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.